{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:59:45Z","timestamp":1792162785902,"version":"4.4.0"},"reference-count":52,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The inhibition of hepatic macrophage and Kupfer cell recruitment and activation is a potential strategy for treating insulin resistance and nonalcoholic steatohepatitis (NASH). Cenicriviroc (CVC), a dual C-C chemokine receptor 2 (CCR2) and CCR5 antagonist, has shown antifibrotic activity in murine models of NASH and has been evaluated in clinical trials on patients with NASH. This study investigated the effects of CVC on macrophage infiltration and polarization in a lipotoxic model of NASH. C57BL\/6 mice were fed a high-cholesterol, high-fat (CL) diet or a CL diet containing 0.015% CVC (CL + CVC) for 12 weeks. Macrophage recruitment and activation were assayed by immunohistochemistry and flow cytometry. CVC supplementation attenuated excessive hepatic lipid accumulation and peroxidation and alleviated glucose intolerance and hyperinsulinemia in the mice that were fed the CL diet. Flow cytometry analysis revealed that compared with the CL group, mice fed the CL + CVC diet had fewer M1-like macrophages, more M2-like macrophages, and fewer T cell counts, indicating that CVC caused an M2-dominant shift of macrophages in the liver. Similarly, CVC decreased lipopolysaccharide-stimulated M1-like macrophage activation, whereas it increased interleukin-4-induced M2-type macrophage polarization in vitro. In addition, CVC attenuated hepatic fibrosis by repressing hepatic stellate cell activation. Lastly, CVC reversed insulin resistance as well as steatosis, inflammation, and fibrosis of the liver in mice with pre-existing NASH. In conclusion, CVC prevented and reversed hepatic steatosis, insulin resistance, inflammation, and fibrogenesis in the liver of NASH mice via M2 macrophage polarization.<\/jats:p>","DOI":"10.1210\/endocr\/bqae069","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T07:54:13Z","timestamp":1718092453000},"source":"Crossref","is-referenced-by-count":8,"title":["Cenicriviroc Suppresses and Reverses Steatohepatitis by Regulating Macrophage Infiltration and M2 Polarization in Mice"],"prefix":"10.1210","volume":"165","author":[{"given":"Guanliang","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Cell Metabolism and Nutrition, Graduate School of Medical Sciences, Kanazawa University , Kanazawa 920-8640, Ishikawa , Japan"},{"name":"Jiangsu Carephar Pharmaceutical Co. Ltd. , No.6 Xuzhuang Road, Xuanwu District, Nanjing 210014, Jiangsu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Yu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University , Wenzhou 325035, Zhejiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University , Wenzhou 325035, Zhejiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2714-6395","authenticated-orcid":false,"given":"Mayumi","family":"Nagashimada","sequence":"additional","affiliation":[{"name":"Department of Cell Metabolism and Nutrition, Graduate School of Medical Sciences, Kanazawa University , Kanazawa 920-8640, Ishikawa , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University , Wenzhou 325035, Zhejiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Cell Metabolism and Nutrition, Graduate School of Medical Sciences, Kanazawa University , Kanazawa 920-8640, Ishikawa , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4238-9061","authenticated-orcid":false,"given":"Liang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cell Metabolism and Nutrition, Graduate School of Medical Sciences, Kanazawa University , Kanazawa 920-8640, Ishikawa , Japan"},{"name":"Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University , Wenzhou 325035, Zhejiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"issue":"8","key":"2024070101470535300_bqae069-B1","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: an update","volume":"65","author":"Katsiki","year":"2016","journal-title":"Metab Clin Exp"},{"issue":"6","key":"2024070101470535300_bqae069-B2","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jhep.2022.07.020","article-title":"Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD","volume":"77","author":"Kim","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"2024070101470535300_bqae069-B3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jhep.2021.11.012","article-title":"MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis","volume":"76","author":"Noureddin","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"2024070101470535300_bqae069-B4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"2024070101470535300_bqae069-B5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease\u2014a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"Suppl","key":"2024070101470535300_bqae069-B6","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.3350\/cmh.2022.0392","article-title":"Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management","volume":"29","author":"Battistella","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"2024070101470535300_bqae069-B7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"2024070101470535300_bqae069-B8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/d41573-024-00051-1","article-title":"NASH field celebrates \u2018hurrah moment\u2019 with a first FDA drug approval for the liver disease","volume":"23","author":"Kingwell","year":"2024","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2024070101470535300_bqae069-B9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"2024070101470535300_bqae069-B10","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.3389\/fimmu.2018.01930","article-title":"Chemokine-induced macrophage polarization in inflammatory conditions","volume":"9","author":"Ruytinx","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"2024070101470535300_bqae069-B11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"2024070101470535300_bqae069-B12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jcmgh.2023.03.002","article-title":"The multifaceted roles of macrophages in NAFLD pathogenesis","volume":"15","author":"Vonderlin","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"8","key":"2024070101470535300_bqae069-B13","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","article-title":"Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease","volume":"54","author":"Mulder","year":"2021","journal-title":"Immunity"},{"issue":"9","key":"2024070101470535300_bqae069-B14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41577-023-00848-y","article-title":"Tissue-specific macrophages: how they develop and choreograph tissue biology","volume":"23","author":"Mass","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2024070101470535300_bqae069-B15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0040-1708876","article-title":"Hepatic stellate cell-macrophage crosstalk in liver fibrosis and carcinogenesis","volume":"40","author":"Matsuda","year":"2020","journal-title":"Semin Liver Dis"},{"key":"2024070101470535300_bqae069-B16","doi-asserted-by":"crossref","first-page":"154914","DOI":"10.1016\/j.metabol.2021.154914","article-title":"CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1\/M2 status in mice","volume":"125","author":"Xu","year":"2021","journal-title":"Metabolism"},{"key":"2024070101470535300_bqae069-B17","doi-asserted-by":"crossref","first-page":"155272","DOI":"10.1016\/j.metabol.2022.155272","article-title":"CX3CL1\/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1\/M2 status","volume":"136","author":"Ni","year":"2022","journal-title":"Metab Clin Exp"},{"issue":"3","key":"2024070101470535300_bqae069-B18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"Baeck","year":"2012","journal-title":"Gut"},{"issue":"11","key":"2024070101470535300_bqae069-B19","doi-asserted-by":"crossref","first-page":"G1310","DOI":"10.1152\/ajpgi.00365.2011","article-title":"Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2","volume":"302","author":"Miura","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"2024070101470535300_bqae069-B20","doi-asserted-by":"crossref","first-page":"e0158156","DOI":"10.1371\/journal.pone.0158156","article-title":"Antifibrotic effects of the dual CCR2\/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis","volume":"11","author":"Lefebvre","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"2024070101470535300_bqae069-B21","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"2024070101470535300_bqae069-B22","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.31108","article-title":"Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study","volume":"72","author":"Ratziu","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"2024070101470535300_bqae069-B23","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/hep.28682","article-title":"Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury","volume":"64","author":"Mossanen","year":"2016","journal-title":"Hepatology"},{"key":"2024070101470535300_bqae069-B24","doi-asserted-by":"crossref","first-page":"D1899","DOI":"10.2741\/A887","article-title":"Chemokines in liver inflammation and fibrosis","volume":"7","author":"Marra","year":"2002","journal-title":"Front Biosci"},{"issue":"3","key":"2024070101470535300_bqae069-B25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1210\/en.2014-1776","article-title":"Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, \u03b2-cryptoxanthin","volume":"156","author":"Ni","year":"2015","journal-title":"Endocrinology"},{"issue":"6","key":"2024070101470535300_bqae069-B26","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jnutbio.2012.08.011","article-title":"Lycopene suppresses proinflammatory response in lipopolysaccharide-stimulated macrophages by inhibiting ROS-induced trafficking of TLR4 to lipid raft-like domains","volume":"24","author":"Zou","year":"2013","journal-title":"J Nutr Biochem"},{"issue":"19","key":"2024070101470535300_bqae069-B27","doi-asserted-by":"crossref","first-page":"15047","DOI":"10.18632\/oncotarget.24587","article-title":"A porcine placental extract prevents steatohepatitis by suppressing activation of macrophages and stellate cells in mice","volume":"9","author":"Xu","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"2024070101470535300_bqae069-B28","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.21874","article-title":"Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet","volume":"46","author":"Matsuzawa","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"2024070101470535300_bqae069-B29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jcmgh.2020.08.012","article-title":"Roles of CCR2 and CCR5 for hepatic macrophage polarization in mice with liver parenchymal cell-specific nemo deletion","volume":"11","author":"Bartneck","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"2024070101470535300_bqae069-B30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"issue":"24","key":"2024070101470535300_bqae069-B31","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1007\/s00018-019-03255-6","article-title":"Dual CCR5\/CCR2 targeting: opportunities for the cure of complex disorders","volume":"76","author":"Fantuzzi","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"2024070101470535300_bqae069-B32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4196\/kjpp.2019.23.6.459","article-title":"Efficacy of evogliptin and cenicriviroc against nonalcoholic steatohepatitis in mice: a comparative study","volume":"23","author":"Wang","year":"2019","journal-title":"Korean J Physiol Pharmacol"},{"issue":"5","key":"2024070101470535300_bqae069-B33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hep4.1160","article-title":"Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitis","volume":"2","author":"Kruger","year":"2018","journal-title":"Hepatol Commun"},{"issue":"1","key":"2024070101470535300_bqae069-B34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","article-title":"Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: AURORA Phase III Randomized Study","volume":"22","author":"Anstee","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"2024070101470535300_bqae069-B35","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jhep.2023.01.024","article-title":"An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease","volume":"78","author":"Lee","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"2024070101470535300_bqae069-B36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.26607","article-title":"M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease","volume":"59","author":"Wan","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"2024070101470535300_bqae069-B37","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm.1964","article-title":"CD8+ effector t cells contribute to macrophage recruitment and adipose tissue inflammation in obesity","volume":"15","author":"Nishimura","year":"2009","journal-title":"Nat Med"},{"issue":"3","key":"2024070101470535300_bqae069-B38","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.26749","article-title":"Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH","volume":"59","author":"Sutti","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"2024070101470535300_bqae069-B39","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.30249","article-title":"Pharmacological inhibition of CCR2\/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice","volume":"69","author":"Ambade","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"2024070101470535300_bqae069-B40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40139-015-0094-y","article-title":"Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver","volume":"3","author":"Park","year":"2015","journal-title":"Curr Pathobiol Rep"},{"key":"2024070101470535300_bqae069-B41","doi-asserted-by":"crossref","first-page":"17192","DOI":"10.1038\/srep17192","article-title":"Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: a comparison with vitamin E","volume":"5","author":"Ni","year":"2015","journal-title":"Sci Rep"},{"key":"2024070101470535300_bqae069-B42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.freeradbiomed.2019.11.036","article-title":"Lycopene prevents the progression of lipotoxicity-induced nonalcoholic steatohepatitis by decreasing oxidative stress in mice","volume":"152","author":"Ni","year":"2020","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"2024070101470535300_bqae069-B43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCRESAHA.108.181040","article-title":"Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2","volume":"104","author":"Bae","year":"2009","journal-title":"Circ Res"},{"issue":"9","key":"2024070101470535300_bqae069-B44","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1084\/jem.193.9.1087","article-title":"Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation","volume":"193","author":"Mathew","year":"2001","journal-title":"J Exp Med"},{"key":"2024070101470535300_bqae069-B45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4939-9195-2_17","article-title":"Analysis of IL-4\/STAT6 signaling in macrophages","volume":"1966","author":"Waqas","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"2","key":"2024070101470535300_bqae069-B46","doi-asserted-by":"crossref","first-page":"F319","DOI":"10.1152\/ajprenal.00432.2002","article-title":"Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury","volume":"285","author":"Yokota","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"issue":"48","key":"2024070101470535300_bqae069-B47","doi-asserted-by":"crossref","first-page":"33391","DOI":"10.1074\/jbc.M114.579870","article-title":"Asbestos-induced disruption of calcium homeostasis induces endoplasmic reticulum stress in macrophages","volume":"289","author":"Ryan","year":"2014","journal-title":"J Biol Chem"},{"issue":"3","key":"2024070101470535300_bqae069-B48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"24","key":"2024070101470535300_bqae069-B49","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1021\/acs.jmedchem.7b00907","article-title":"Discovery of tropifexor (LJN452), a highly potent non-bile acid FXR agonist for the treatment of cholestatic liver diseases and nonalcoholic steatohepatitis (NASH)","volume":"60","author":"Tully","year":"2017","journal-title":"J Med Chem"},{"issue":"1","key":"2024070101470535300_bqae069-B50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhep.2021.03.020","article-title":"FXR agonists for NASH how are they different and what difference do they make","volume":"75","author":"Kremoser","year":"2021","journal-title":"J Hepatol"},{"issue":"8","key":"2024070101470535300_bqae069-B51","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/liv.14943","article-title":"Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"41","author":"Burra","year":"2021","journal-title":"Liver Int"},{"issue":"12","key":"2024070101470535300_bqae069-B52","doi-asserted-by":"crossref","first-page":"108363","DOI":"10.1016\/j.isci.2023.108363","article-title":"Sex difference in liver diseases: how preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and HCC","volume":"26","author":"Smiriglia","year":"2023","journal-title":"Iscience"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqae069\/58199510\/bqae069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/165\/7\/bqae069\/58358485\/bqae069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/165\/7\/bqae069\/58358485\/bqae069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T01:47:46Z","timestamp":1719798466000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqae069\/7691246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,5,27]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqae069","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,5,27]]},"article-number":"bqae069"}}